SHE:002294 Revenue

Shenzhen Salubris Pharmaceuticals had revenue of 958.43M CNY in the quarter ending September 30, 2024, with 24.15% growth. This brings the company's revenue in the last twelve months to 3.91B, up 15.34% year-over-year. In the year 2023, Shenzhen Salubris Pharmaceuticals had annual revenue of 3.37B, down -3.35%.

Revenue (ttm)

3.91B

Revenue Growth

+15.34%

P/S Ratio

8.47

Revenue / Employee

1.11M

Employees

3,517

Market Cap

33.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.37B	-116.67M	-3.35%
Jan 1, 2023	3.48B	423.62M	13.85%
Jan 1, 2022	3.06B	319.83M	11.68%
Dec 31, 2020	2.74B	-1.73B	-38.74%
Dec 31, 2019	4.47B	-181.41M	-3.90%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.93B
Yunnan Baiyao Group Co.,Ltd	39.34B
Beijing Wantai Biological Pharmacy Enterprise	2.49B

Revenue Rankings